七部门发布脑机接口重磅政策！产业发展提速，监管挑战仍在

Core Viewpoint - The brain-computer interface (BCI) industry is transitioning from a fragmented approach to a coordinated national strategy, aiming for sustainable development and innovation in the sector [1][3]. Group 1: Policy and Strategic Goals - The Ministry of Industry and Information Technology and other departments have issued an implementation opinion to promote the innovation and development of the BCI industry, outlining five key tasks and 17 specific measures [1][2]. - By 2027, breakthroughs in key BCI technologies are expected, with the establishment of advanced technical, industrial, and standard systems, and products reaching international standards [1][2]. - By 2030, the BCI industry aims to cultivate 2 to 3 globally influential leading enterprises and a number of specialized small and medium-sized enterprises, enhancing its international competitiveness [1]. Group 2: Industry Development and Application - The BCI industry is entering a new historical development phase, with a focus on accelerating the application of technology and innovation [3][4]. - The implementation opinion emphasizes the importance of enhancing basic hardware and software capabilities, promoting the application of technological achievements, and improving product interoperability and usability [3][4]. - Companies are expected to increase R&D investments in critical areas such as biocompatible materials and minimally invasive implantation techniques [5][6]. Group 3: Funding and Support - The implementation opinion encourages increased funding support for the BCI industry, including investments from national manufacturing transformation funds and small enterprise development funds [4][5]. - This financial backing is anticipated to accelerate the development of core components and systems in the BCI sector, particularly in key industrialization processes [4][5]. Group 4: Standards and Regulatory Challenges - The sustainable development of the BCI industry relies on the establishment of a comprehensive standard system, including communication protocols for various BCI components [7][8]. - The opinion highlights the need for a data governance framework to protect user information and enhance the security of biological digital information [7][8]. - There are calls for a structured approach to clinical trials and data management to ensure the safety and efficacy of BCI products, particularly in sensitive areas involving brain data [9][10].